These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6281294)

  • 1. Cimetidine treatment of azotemic secondary hyperparathyroidism.
    Robinson MF; Johnson WJ; Heath H
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1206-9. PubMed ID: 6281294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1).
    Robinson MF; Hayles AB; Heath H
    J Clin Endocrinol Metab; 1980 Oct; 51(4):912-4. PubMed ID: 6106649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs.
    Jacob AI; Canterbury JM; Gavellas G; Lambert PW; Bourgoignie JJ
    J Clin Invest; 1981 Jun; 67(6):1753-60. PubMed ID: 7240419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
    Glaser B; Kraiem Z; Rotem M; Gonda M; Bernheim J; Sheinfeld M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):993-7. PubMed ID: 6090499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation between changes in immunoreactive parathormone and its biological indices induced by cimetidine in primary hyperparathyroidism.
    van der Velden PC; Fischer HR; Hackeng WH; Schopman W; Koorevaar G; den Ottolander GJ; Silberbusch J
    Acta Med Scand; 1981; 210(6):467-70. PubMed ID: 6277160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
    Makdassi R; Decourcelle PH; Moriniere P; Coevoet B; de Fremont JF; Kassouf J; Roussel A; Gheerbrand JD; Andrejak M; Fournier A
    Proc Eur Dial Transplant Assoc; 1981; 18():642-7. PubMed ID: 7329992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intravenous and oral cimetidine in primary hyperparathyroidism.
    Wiske PS; Epstein S; Norton JA; Bell NH; Johnston CC
    Horm Metab Res; 1983 May; 15(5):245-8. PubMed ID: 6873872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
    Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
    N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.
    Jara A; Felsenfeld AJ; Bover J; Kleeman CR
    Kidney Int; 2000 Sep; 58(3):1023-32. PubMed ID: 10972667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.
    Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW
    J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
    Sebert JL; Decourcelles PH; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
    Miner Electrolyte Metab; 1982 Dec; 8(6):293-9. PubMed ID: 7167135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cimetidine treatment of primary hyperparathyroidism].
    Caron P; Gaillard J; Barousse C; Bouissou H; Louvet JP; Boulard C
    Ann Med Interne (Paris); 1984; 135(1):12-5. PubMed ID: 6322636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: role of histamine H2 receptors.
    Williams GA; Longley RS; Bowser EN; Hargis GK; Kukreja SC; Vora NM; Johnson PA; Jackson BL; Kawahara WJ; Henderson WJ
    J Clin Endocrinol Metab; 1981 Jan; 52(1):122-7. PubMed ID: 7451639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE; Mahaffey JE; Bartter FC; Neer RM
    J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cimetidine therapy of hyperparathyroidism?].
    Windeck R; Benker G; Hoff HG; Reinwein D
    Dtsch Med Wochenschr; 1981 Oct; 106(43):1433-5. PubMed ID: 7285829
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
    Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
    Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.